Nephrotic syndrome from 5-ASA for ulcerative colitis?: Complicated by carcinoma of the colon and sclerosing cholangitis

Journal of Clinical Gastroenterology

Volumn 24, Issue 1, 1997, Pages 37-39

  Fornaciari, Giovanni ^a   Maccari, Sergio ^a   Borgatti, Pier Paolo ^a   Rustichelli, Roberto ^a   Amelio, Nicola ^a   Lattuada, Ivana ^a   Plancher, Angelo Cesare ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

5 ASA; Carcinoma; Colon; Nephrotic syndrome; Sclerosing cholangitis; Ulcerative colitis

Indexed keywords

ALKALINE PHOSPHATASE; LIVER ENZYME; MESALAZINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ANALGESIC NEPHROPATHY; ARTICLE; CASE REPORT; COLON CARCINOMA; COLON RESECTION; DISEASE ASSOCIATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTIC SYNDROME; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AMINOSALICYLIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; HUMANS; MALE; MESALAMINE; NEPHROTIC SYNDROME;

EID: 0031029615     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199701000-00008     Document Type: Article

References (23)

1. Calder IC, Funder CC, Green CR, Ham KN, Tange JD. Nephotoxicity lesion from 5-aminosalicylic acid. Br Med J 1972;1: 152-4.
2. Novis BH, Korzets Z, Chen P, Berheim J. Nephrotic syndrome after treatment with 5-aminosalicylic acid. BMJ 1988;296:1442.
3. Ruf-Ballauf W, Hofstadter F, Krentz F. Akute interstitielle nephritis durch 5-amynosalicylsaure. Internist 1989;30:262-4.
4. Henning HV, Meinhold J, Eisenhauer T, Scheler F. Chronische interstitielle Nephritis nach Benandlung mit 5-aminosalicylsaure. Dtsch Med Wochenschr 1989;114:1091.
5. Von Muhlendahl KE. Nephritis durch 5-aminosalicylsaure. Dtsch Med Wochenschr 1989;114:236.
6. Committee on Safety of Medicines. Nephrotoxicity associated with mesalazine. Current Probl 1990;30:2.
7. Thuluvath PJ, Ninkovic M, Calam J, Anderson M. Mesalazine induced interstitial nephritis. Gut 1994;35:1493-6.
8. Metha RP. Acute interstitial nephritis due to 5-aminosalicylic acid. Can Med Assoc J 1990;143:1031-2.
9. Barbour VM, Williams PF. Nephrotic syndrome associated with sulphasalazine. BMJ 1990;301:818.
10. Jarnerot G. New salicylates as maintenance treatment in ulcerative colitis. Gut 1994;35:1155-8.
11. Dwarakanath AD, Michael J, Allan RN. Sulphasalazine induced renal failure. Gut 1992;33:1006-7.
12. Lee JC, Yamauchi H, Hopper J Jr. The association of cancer and the nephrotic syndrome: Ann Intern Med 1966;64:41-51.
13. Eagen JW, Lewis EJ. Glomerulopathies of neoplasia. Kidney Int 1977;11:297-306.
14. Dabbs DJ, Morel-Maroger Striker L, Mignon F, Striker G. Glomerular lesions in lymphomas and leukemias. Am J Med 1986; 80:63-70.
15. Martienz-Vea A, Panisello JM, Garcia C, et al. Minimal change glomerulopathy and carcinoma. Am J Nephrol 1993;13:69-72.
16. Gandini E, Allaria P, Castiglioni A, D'Amato I, Schiaffino E, Giangrande A. Minimal change nephrotic syndrome with cecum adenocarcinoma. Clin Nephrol 1996;45:268-70.
17. Caruana RJ, Griffin JW. Nephrotic syndrome in a patient with ulcerative colitis and colonic carcinoma. Am J Gastroenterol 1980; 74:525-8.
18. Meyrier A, Delahousse M, Callard P, Rainfray M. Minimal change nephrotic syndrome revealing solid tumors. Nephron 1992;61: 220-3.
19. Wilcox GM, Aretz HT, Roy MA, Roche JK. Glomerulonephritis associated with inflammatory bowel disease: Report of a patient with chronic ulcerative colitis, sclerosing cholangitis and acute glomerulonephritis. Gastroenterology 1990;98:786-91.
20. Moayyedi P, Fletcher S, Harnden P, Axon ATR, Brownjohn A. Mesangiocapillary glomerulonephritis associated with ulcerative colitis: case reports of two patients. Nephrol Dial Transplant 1995; 10:1923-4.
21. Kaplan MM, Arora S, Pincus SH. Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Ann Intern Med 1987;106:231-5.
22. Stokke KT, Teisberg PA, Myhre E, Hovig T, Flatmark A, Gjone E. Nephotic syndrome in ulcerative colitis. Scand J Gastroenterol 1976;11:571-6.
23. Broomé U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995;22:1404-8.